Neurobiology of DiseaseNeurosciencePeer-reviewed journal article
Tunable Tau Expression in C. elegans Neurons Reveals that Early-AD Tau Phosphorylation Selectively Impacts Behavior and Mitochondrial Quality Control
Thomas CarrolliD, Dylan Pfendler, Haya Alhaj Arhayem, R. Thoma, Annika Müller-EigneriD, A. Straut, G.V.W. Johnson, K. Nehrke
Abstract
Tau protein accumulates myriad post-translational modifications as Alzheimers disease (AD) progresses, and early-disease tau modifications such as phosphorylation at threonine 231 (T231) likely play a key role in AD pathogenesis. Here, a series of "tunable tau" strains was developed in C. elegans to test the relative impact of tau pseudo-phosphorylation of T231 (T231E) compared to protein expression level as a driver of phenotypic penetrance and severity. Multiple copies of a cassette coding for pan-neuronal wildtype tau or T231E were inserted at a genomic safe harbor loci to create a repertoire of strains expressing tau from low to high levels. In stereotypical behavioral assays of locomotory activity, T231E selectively impacted phenotypic severity compared to wild-type human tau controls, which further tracked with age and tau expression level. However, deficits in associative memory were non-selective between tau and T231E. Moreover, genetic, pharmacologic, and molecular approaches indicated that mitophagy modulation could suppress T231E phenotypes. Additionally, a robust mitochondrial unfolded protein response (UPRmt) occurred in T231E, and loss of atfs-1, a transcription factor central to the UPRmt suppressed T231E toxicity. These results demonstrate that phenotypic severity is invariably associated with tau dosage, while early-AD relevant modifications can be causative drivers of selective deficits. Consistent with recent findings, enhancing mitophagy or suppressing potentially maladaptive consequences of persistent UPRmt induction can be beneficial. This provides a solid foundation for further interrogation into mitochondrial quality control disruption as a potential root cause for AD pathogenesis. HighlightsO_LIMatched sets of pan-neuronal, multi-copy tau strains enhance experimental control C_LIO_LIPhosphomimetic tau elicits selective behavioral and neuronal dysfunction C_LIO_LIPhosphomimetic tau triggers a unique mitochondrial unfolded response C_LIO_LITau depletion and mitochondrial interventions rescue observed deficits C_LI Visual Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=168 SRC="FIGDIR/small/701793v1_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@c5afb3org.highwire.dtl.DTLVardef@921b6corg.highwire.dtl.DTLVardef@466f8borg.highwire.dtl.DTLVardef@45452f_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 15th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alzheimer's disease-relevant tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
Sanjib K Guha, Sarah Fischer, … Keith W. Nehrke·Molecular NeurodegenerationPeer-reviewed·Nov 9, 2020
- Tau Clearance Reverses Neuronal Dysfunction in Both Young and Aged C. elegans
Trae Carroll, Gail V.W. Johnson, Keith W. Nehrke·bioRxiv·Jun 23, 2025
- Site-specific phosphorylation of tau impacts mitochondrial biology and response to stressors
Michael O. Isei, Peter Girardi, … Gail V.W. Johnson·bioRxiv·Feb 19, 2023
- Targeting mTOR restores tau-induced metabolic, mitochondrial, and cognitive deficits in a tauopathy mouse model
Zhi Tang, Min Guo, … Xiaolan Qi·bioRxiv·Nov 24, 2024
- Mimicking of tau hyperphosphorylation in GABAergic motoneurons of C. elegans induces severe peripheral and neuronal alterations
Audrey Labarre, Emilien Schramm, … J. Alex Parker·bioRxiv·Jul 4, 2023
- Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Ab1-42 and mutant Tau
Franziska Hirsch, Nino F. Läubli, … Janine Kirstein·Disease Models & MechanismsPeer-reviewed·Feb 23, 2026